【摘 要】

    目的：探讨利伐沙班治疗急性肺栓塞的疗效。方法：选取2018年7月-2019年7月我院收治的急性肺栓塞患者114例，随机分为两组，对照组应用华法林治疗，研究组应用利伐沙班治疗。结果：研究组治疗有效率显著优于对照组(P<0.05);研究组患者不良反应情况低于对照组(P<0.05)。结论：利伐沙班对急性肺栓塞患者有很好的治疗效果，能够降低不良反应的发生率，提高患者的生活质量，值得在临床治疗上大力推广应用。

    【关键词】 利伐沙班;急性肺栓塞;治疗效果

    【中图分类号】R563.5 【文献标志码】A 【文章编号】1005-0019(2020)02-045-02

    Abstract：

    Objective：To investigate the efficacy of rivaroxaban in the treatment of acute pulmonary embolism. Methods：114 patients with acute pulmonary embolism treated in our hospital from July 2018 to July 2019 were randomly divided into two groups. The control group was treated with warfarin and the research group was treated with rivaroxaban. Results：The treatment efficiency of the study group was significantly better than that of the control group (P <0.05). The adverse reactions of the study group were lower than those of the control group (P <0.05). Conclusion：Rivaroxaban has a good therapeutic effect on patients with acute pulmonary embolism. It can reduce the incidence of adverse reactions and improve the quality of life of patients. It is worthy of vigorous promotion and application in clinical treatment. ......